Literature DB >> 2212954

Activation of platelets by eosinophil granule proteins.

M S Rohrbach1, C L Wheatley, N R Slifman, G J Gleich.   

Abstract

Two of the four principal cationic proteins of the eosinophil granule, major basic protein (MBP) and eosinophil peroxidase (EPO), were shown to be platelet agonists. Both MBP and EPO evoked a dose-dependent nonlytic secretion of platelet 5-hydroxytryptamine in unstirred platelet suspensions even in the presence of 10 microM indomethacin. MBP also evoked secretion of platelet alpha granule and lysosome components. Secretion by MBP and EPO was inhibited by 1 microM PGE1, but the nature of the inhibition differed from that observed with thrombin. Thus, MBP and EPO can be classified as strong platelet agonists with a distinct mechanism of activation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2212954      PMCID: PMC2188607          DOI: 10.1084/jem.172.4.1271

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

Review 1.  The eosinophil and bronchial asthma: current understanding.

Authors:  G J Gleich
Journal:  J Allergy Clin Immunol       Date:  1990-02       Impact factor: 10.793

2.  Interrelations of platelet aggregation and secretion.

Authors:  I F Charo; R D Feinman; T C Detwiler
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

3.  Inhibition of platelet energy production and release reaction by PGE1, theophylline and cAMP.

Authors:  S M Wolfe; N R Shulman
Journal:  Biochem Biophys Res Commun       Date:  1970-10-09       Impact factor: 3.575

Review 4.  Relation between eosinophilia and endomyocardial disease.

Authors:  E G Olsen; C J Spry
Journal:  Prog Cardiovasc Dis       Date:  1985 Jan-Feb       Impact factor: 8.194

5.  Eosinophil-mediated mammalian tumor cell cytotoxicity: role of the peroxidase system.

Authors:  E C Jong; S J Klebanoff
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

6.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

7.  Platelet 5-hydroxytryptamine release and aggregation promoted by cotton bracts tannin.

Authors:  M S Rohrbach; R A Rolstad; P B Tracy; J A Russell
Journal:  J Lab Clin Med       Date:  1984-01

8.  Purification of human eosinophil-derived neurotoxin.

Authors:  D T Durack; S J Ackerman; D A Loegering; G J Gleich
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

9.  The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X.

Authors:  K Fredens; R Dahl; P Venge
Journal:  J Allergy Clin Immunol       Date:  1982-11       Impact factor: 10.793

10.  Eosinophil peroxidase-induced mast cell secretion.

Authors:  W R Henderson; E Y Chi; S J Klebanoff
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

View more
  42 in total

1.  Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts.

Authors:  G T Furuta; S J Ackerman; J Varga; A M Spiess; M Y Wang; B K Wershil
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

Review 2.  Mammalian antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

Review 3.  Cardiac manifestation of the hypereosinophilic syndrome: new insights.

Authors:  T Kleinfeldt; C A Nienaber; S Kische; I Akin; R G Turan; T Körber; H Schneider; H Ince
Journal:  Clin Res Cardiol       Date:  2010-03-24       Impact factor: 5.460

4.  White blood count and infarct size, myocardial salvage and clinical outcomes: the role of differentials.

Authors:  Nicholas G Kounis; George D Soufras; Grigorios Tsigkas; George Hahalis
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-03       Impact factor: 2.357

Review 5.  Eosinophils and disease pathogenesis.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Semin Hematol       Date:  2012-04       Impact factor: 3.851

6.  Macrophage-mediated candidacidal activity is augmented by exposure to eosinophil peroxidase: a paradigm for eosinophil-macrophage interaction.

Authors:  D L Lefkowitz; J A Lincoln; K R Howard; R Stuart; S S Lefkowitz; R C Allen
Journal:  Inflammation       Date:  1997-04       Impact factor: 4.092

7.  Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps.

Authors:  Charlotte Marx; Julia Novotny; Danby Salbeck; Katie R Zellner; Leo Nicolai; Kami Pekayvaz; Badr Kilani; Sven Stockhausen; Niklas Bürgener; Danny Kupka; Thomas J Stocker; Ludwig T Weckbach; Joachim Pircher; Markus Moser; Michael Joner; Walter Desmet; Tom Adriaenssens; Franz-Josef Neumann; Anthony H Gerschlick; Jurrien M Ten Berg; Michael Lorenz; Konstantin Stark
Journal:  Blood       Date:  2019-11-21       Impact factor: 22.113

Review 8.  Bidirectional modulation of platelet and polymorphonuclear leukocyte activities.

Authors:  A Del Maschio; E Dejana; G Bazzoni
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

Review 9.  Eosinophils in the 1990s: new perspectives on their role in health and disease.

Authors:  A J Wardlaw
Journal:  Postgrad Med J       Date:  1994-08       Impact factor: 2.401

10.  Sudden death of a patient with primary hypereosinophilia, colon tumours, and pulmonary emboli.

Authors:  K Uemura; M Nakajima; N Yamauchi; M Fukayama; K Yoshida
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.